Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M28,058Revenue (TTM) $M3,472Net Margin (%)14.6Altman Z-Score4.3
Enterprise Value $M29,792EPS (TTM) $2.2Operating Margin %18.6Piotroski F-Score8
P/E(ttm)56.1Beneish M-Score-2.6Pre-tax Margin (%)16.2Higher ROA y-yY
Price/Book3.110-y EBITDA Growth Rate %--Quick Ratio2.5Cash flow > EarningsY
Price/Sales8.25-y EBITDA Growth Rate %26.5Current Ratio3.0Lower Leverage y-yY
Price/Free Cash Flow32.9y-y EBITDA Growth Rate %4.2ROA % (ttm)3.8Higher Current Ratio y-yY
Dividend Yield %--PEG2.1ROE % (ttm)5.8Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M223ROIC % (ttm)5.5Gross Margin Increase y-yN

Gurus Latest Trades with ALXN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

ALXN is held by these investors:



ALXN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
HANTSON LUDWIGCEO 2018-01-02Sell2,553$121.633.26view
Wagner Heidi LSVP, Global Government Affairs 2017-10-02Sell120$140-10.29view
O'Neill JulieEVP. Global Operations 2017-09-05Sell4,375$145.44-13.65view
Veneman Ann MDirector 2017-09-05Sell835$145.81-13.87view
O'Neill JulieEVP. Global Operations 2017-08-28Sell11,160$140-10.29view
Veneman Ann MDirector 2017-07-31Sell700$137.74-8.82view
COUGHLIN CHRISTOPHER JDirector 2017-06-15Buy2,000$117.17.25view
PARVEN ALVIN SDirector 2017-06-15Sell835$116.787.54view
BAKER BROS. ADVISORS LPDirector 2017-06-15Buy660,779$117.337.04view
BAKER BROS. ADVISORS LPDirector 2017-06-14Buy1,348,955$116.327.97view

Press Releases about ALXN :

Quarterly/Annual Reports about ALXN:

News about ALXN:

Articles On GuruFocus.com
Factors of Influence in 2018, Key Indicators and Opportunity within Intuit, Alexion Pharmaceuticals, Dec 06 2017 
Investor Expectations to Drive Momentum within Carrizo, Coeur, Alexion, Ultra Clean, Alaska Air, and Nov 08 2017 
ALEXION INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investi Oct 06 2017 
Why Markets Might Have Got It Wrong With Omeros Aug 29 2017 
Daniel Loeb Buys 8 Stocks in 2nd Quarter Aug 16 2017 
7 Assets With Negative Performances Jul 17 2017 
Spiros Segalas Commentary on Alexion Pharmaceuticals Jul 10 2017 
Spiros Segalas' Harbor Capital Appreciation Fund Managers' Commentary Jul 10 2017 
Weekly Top Insider Buys Highlight for the Week of June 16 Jun 17 2017 
Lifshitz & Miller LLP Announces Investigation of Akari Therapeutics, Plc, Alexion Pharmaceuticals, I May 30 2017 

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK